<p>Broncus Holding Corp.（香港股票代码：2216）刚刚发布了一项公告。</p>
<p>Broncus Holding Corp.宣布在一般授权下拟发行股份，同意以每股 HK$3.11 配发和发行 105,108,015 股认购股份。这一举措约占公司已发行股本的 19.90%，预计将筹集 HK$326.9 百万的总收入，以支持公司在医疗器械行业的扩展。认购协议的完成需满足某些条件，建议利益相关者谨慎行事。</p>
<p>（香港股票代码：2216）的最新分析师评级为持有，目标价格为 HK$3.00。要查看 Broncus Holding Corp.股票的完整分析师预测列表，请访问 HK:2216 股票预测页面。</p>
<p><strong>关于 Broncus Holding Corp.的更多信息</strong></p>
<p>Broncus Holding Corp.是一家在开曼群岛注册的公司，主要专注于医疗器械行业。它通过潜在收购扩展其产品组合，表明其在医疗保健领域的战略增长重点。</p>
<p><strong>平均交易量：</strong> 3,927,575</p>
<p><strong>技术情绪信号：</strong> 买入</p>
<p><strong>当前市值：</strong> HK$1.73B</p>
<p>要对 2216 股票进行全面评估，请访问 TipRanks 的股票分析页面。</p>

堃博医疗-B

<p>Broncus Holding Corp.（香港股票代码：2216）宣布拟发行 105,108,015 股认购股份，发行价为每股 3.11 港元，旨在为医疗设备领域的扩展筹集 3.269 亿港元。这相当于其已发行股本的约 19.90%。认购的完成需满足一定条件。分析师目前对该股票的评级为持有，目标价为 3.00 港元。Broncus 专注于通过潜在的医疗保健收购实现增长，市值为 17.3 亿港元</p>

<p>Broncus Holding Corp. ( (HK:2216) ) just unveiled an announcement.</p>
<div class="lb-trans"><p>Broncus Holding Corp.（香港股票代码：2216）刚刚发布了一项公告。</p>
</div><p>Broncus Holding Corp. announced a proposed issue of shares under a general mandate, agreeing to allot and issue 105,108,015 subscription shares at HK$3.11 per share. This move, representing approximately 19.90% of the company’s issued share capital, is expected to raise gross proceeds of HK$326.9 million, which will support the company’s expansion in the medical devices industry. The completion of the subscription agreements is subject to certain conditions, and stakeholders are advised to exercise caution.</p>
<div class="lb-trans"><p>Broncus Holding Corp.宣布在一般授权下拟发行股份，同意以每股 HK$3.11 配发和发行 105,108,015 股认购股份。这一举措约占公司已发行股本的 19.90%，预计将筹集 HK$326.9 百万的总收入，以支持公司在医疗器械行业的扩展。认购协议的完成需满足某些条件，建议利益相关者谨慎行事。</p>
</div><p>The most recent analyst rating on (HK:2216) stock is a Hold with a HK$3.00 price target. To see the full list of analyst forecasts on Broncus Holding Corp. stock, see the HK:2216 Stock Forecast page.</p>
<div class="lb-trans"><p>（香港股票代码：2216）的最新分析师评级为持有，目标价格为 HK$3.00。要查看 Broncus Holding Corp.股票的完整分析师预测列表，请访问 HK:2216 股票预测页面。</p>
</div><p><strong>More about Broncus Holding Corp.</strong></p>
<div class="lb-trans"><p><strong>关于 Broncus Holding Corp.的更多信息</strong></p>
</div><p>Broncus Holding Corp. is a company incorporated in the Cayman Islands, primarily focused on the medical devices industry. It is involved in expanding its product portfolio through potential acquisitions, indicating a strategic focus on growth within the healthcare sector.</p>
<div class="lb-trans"><p>Broncus Holding Corp.是一家在开曼群岛注册的公司，主要专注于医疗器械行业。它通过潜在收购扩展其产品组合，表明其在医疗保健领域的战略增长重点。</p>
</div><p><strong>Average Trading Volume:</strong> 3,927,575</p>
<div class="lb-trans"><p><strong>平均交易量：</strong> 3,927,575</p>
</div><p><strong>Technical Sentiment Signal:</strong> Buy</p>
<div class="lb-trans"><p><strong>技术情绪信号：</strong> 买入</p>
</div><p><strong>Current Market Cap:</strong> HK$1.73B</p>
<div class="lb-trans"><p><strong>当前市值：</strong> HK$1.73B</p>
</div><p>For a thorough assessment of 2216 stock, go to TipRanks’ Stock Analysis page.</p>
<div class="lb-trans"><p>要对 2216 股票进行全面评估，请访问 TipRanks 的股票分析页面。</p>
</div>

堃博控股公司宣布发行股票以筹集资金用于扩张